Impax Laboratories Inc. (IPXL) Tops Q2 EPS by 24c
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Price: $18.30 --0%
Financial Fact:
Other (expense) income, net: -373K
Today's EPS Names:
ODYS, IVF, PARA, More
Financial Fact:
Other (expense) income, net: -373K
Today's EPS Names:
ODYS, IVF, PARA, More
Join SI Premium – FREE
Impax Laboratories Inc. (NASDAQ: IPXL) reported Q2 EPS of $0.60, $0.24 better than the analyst estimate of $0.36. Revenue for the quarter came in at $188.1 million versus the consensus estimate of $155.97 million.
For earnings history and earnings-related data on Impax Laboratories Inc. (IPXL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Jernigan Capital (JCAP) Tops Q2 EPS by 5c
- Bio-key International, Inc. (BKYI) Tops Q2 EPS by 24c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
